LCM
PRCT icon

Legato Capital Management’s Procept Biorobotics PRCT Stock Holding History

Legato Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,435
Closed -$423K – 853
2025
Q4 		$423K Buy
+13,435
New +$446K 0.04% 615
2025
Q3 		– Sell
-23,306
Closed -$1.34M – 608
2025
Q2 		$1.34M Buy
23,306
+11,250
+93% +$636K 0.16% 202
2025
Q1 		$702K Sell
12,056
-19,111
-61% -$1.3M 0.09% 345
2024
Q4 		$2.51M Sell
31,167
-14,663
-32% -$1.25M 0.33% 64
2024
Q3 		$3.67M Sell
45,830
-5,840
-11% -$415K 0.45% 34
2024
Q2 		$3.16M Buy
51,670
+9,701
+23% +$577K 0.43% 39
2024
Q1 		$2.07M Hold
41,969
– – 0.25% 120
2023
Q4 		$1.76M Buy
41,969
+14,160
+51% +$482K 0.23% 133
2023
Q3 		$912K Buy
27,809
+21,039
+311% +$717K 0.13% 266
2023
Q2 		$239K Buy
+6,770
New +$224K 0.03% 501

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Legato Capital Management's PRCT Position: Q1 2026 in Review

Legato Capital Management sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 13,435 shares — an estimated $423K sold.

Legato Capital Management first reported a position in PRCT in Q2 2023 and held it in 10 quarters. The position peaked at $3.67M in Q3 2024. 257 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Legato Capital Management reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Legato Capital Management sold 13,435 Procept Biorobotics shares in Q1 2026, an estimated $423K.
  • Legato Capital Management first reported a position in Procept Biorobotics in Q2 2023 and held it in 10 quarters.
  • Legato Capital Management's Procept Biorobotics position peaked at $3.67M in Q3 2024.
  • 257 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.